DSM saw stable full year organic sales in its Pharma cluster in 2008. Sales and profitability in its Pharmaceutical Products business unit were negatively impacted by the phasing-out of contracts related to the Roche Vitamins acquisition, insourcing by large pharma houses and delays in the commercial development of new products.
DSM
Wednesday 18 February 2009
DSM sees stable year for pharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment